A. Albertí

22.8k total citations · 2 hit papers
400 papers, 15.7k citations indexed

About

A. Albertí is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, A. Albertí has authored 400 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 326 papers in Hepatology, 302 papers in Epidemiology and 35 papers in Rheumatology. Recurrent topics in A. Albertí's work include Hepatitis C virus research (290 papers), Liver Disease Diagnosis and Treatment (226 papers) and Hepatitis B Virus Studies (210 papers). A. Albertí is often cited by papers focused on Hepatitis C virus research (290 papers), Liver Disease Diagnosis and Treatment (226 papers) and Hepatitis B Virus Studies (210 papers). A. Albertí collaborates with scholars based in Italy, United States and United Kingdom. A. Albertí's co-authors include Patrizia Pontisso, Luisa Benvegnù, G. Realdi, Laurent Castéra, Liliana Chemello, Xavier Forns, Giovanna Fattovich, A. Ruol, F. Tremolada and Franco Noventa and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

A. Albertí

394 papers receiving 15.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Non-invasive evaluation of liver fibrosis using transient elastography

2008 1.1k citations Laurent Castéra, Xavier Forns et al. Journal of Hepatology profile →
Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection

1980 377 citations G. Realdi, A. Albertí et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Albertí Italy	62	12.7k	12.5k	1.1k	1.0k	931	400	15.7k
Ferruccio Bonino Italy	56	14.0k 1.1×	14.2k 1.1×	1.4k 1.3×	1.0k 1.0×	735 0.8×	329	17.0k
Gary L. Davis United States	65	10.6k 0.8×	11.6k 0.9×	1.1k 1.0×	1.1k 1.1×	1.6k 1.7×	234	16.3k
Marion G. Peters United States	48	7.0k 0.5×	7.0k 0.6×	1.4k 1.3×	1.1k 1.1×	461 0.5×	211	9.9k
Graham R. Foster United Kingdom	58	8.3k 0.7×	8.3k 0.7×	2.2k 2.0×	2.0k 1.9×	768 0.8×	352	13.0k
Wan‐Long Chuang Taiwan	53	8.3k 0.7×	8.5k 0.7×	733 0.7×	553 0.5×	616 0.7×	513	11.1k
Robert G. Gish United States	68	12.4k 1.0×	12.4k 1.0×	1.7k 1.5×	721 0.7×	431 0.5×	373	16.0k
Janice K. Albrecht United States	48	21.7k 1.7×	23.6k 1.9×	2.9k 2.7×	946 0.9×	2.5k 2.7×	117	26.0k
Ming‐Lung Yu Taiwan	53	7.7k 0.6×	7.4k 0.6×	707 0.6×	502 0.5×	614 0.7×	490	10.8k
Howard C. Thomas United Kingdom	68	12.5k 1.0×	12.1k 1.0×	1.8k 1.6×	1.8k 1.7×	813 0.9×	327	19.5k
Markus Cornberg Germany	54	6.9k 0.5×	7.1k 0.6×	1.8k 1.6×	2.3k 2.3×	319 0.3×	399	10.8k

Countries citing papers authored by A. Albertí

Since Specialization

Citations

This map shows the geographic impact of A. Albertí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Albertí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Albertí more than expected).

Fields of papers citing papers by A. Albertí

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Albertí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Albertí. The network helps show where A. Albertí may publish in the future.

Co-authorship network of co-authors of A. Albertí

This figure shows the co-authorship network connecting the top 25 collaborators of A. Albertí. A scholar is included among the top collaborators of A. Albertí based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Albertí. A. Albertí is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nava, Felice, A. Albertí, Massimo Andreoni, et al.. (2018). Position Paper. Per un programma di eliminazione della Epatite C nella popolazione a rischio dei consumatori di sostanze e dei detenuti. 2 indexed citations

Nava, Felice, A. Albertí, Massimo Andreoni, et al.. (2018). For a program of eradication of hepatitis C in the populations at risk (drug users and convicts). PubMed Central. 3 indexed citations

Arcidiacono, Diletta, Arben Dedja, Cinzia Giacometti, et al.. (2018). Hyperinsulinemia Promotes Esophageal Cancer Development in a Surgically-Induced Duodeno-Esophageal Reflux Murine Model. International Journal of Molecular Sciences. 19(4). 1198–1198. 17 indexed citations

Albertí, A., et al.. (2016). Literature review of the distribution of hepatitis C virus genotypes across Europe. Journal of Medical Virology. 88(12). 2157–2169. 20 indexed citations

Castéra, Laurent, Xavier Forns, & A. Albertí. (2008). Non-invasive evaluation of liver fibrosis using transient elastography. Journal of Hepatology. 48(5). 835–847. 1086 indexed citations breakdown →

Terrault, Norah A., Solko W. Schalm, George Papatheodoridis, et al.. (2007). [483] PRESENCE OF BIOPSY-PROVEN HISTOLOGIC DAMAGE (NECROINFLAMMATION AND FIBROSIS) IS COMMON EVEN WHEN ALT IS LESS THAN 2 × ULN IN PATIENTS WITH CHRONIC HEPATITIS B (CHB). Journal of Hepatology. 46. S184–S184. 7 indexed citations

Young, Brian J., M. Gerotto, Francesca Dal Pero, et al.. (2007). A cirrhosis risk score identifies those chronic hepatitis C infected patients presenting with no liver fibrosis that are at high risk for fibrosis progression. Hepatology. 46. 459–459. 1 indexed citations

Mazzoran, Lucia, Francesca Zorat, Liliana Chemello, et al.. (2001). Human leucocyte interferon-alpha in the treatment of chronic hepatitis C. Digestive and Liver Disease. 33(4). 347–352. 5 indexed citations

Locasciulli, Anna, Maria Grazia Valsecchi, Andrea Bacigalupo, et al.. (1999). THE ROLE OF HEPATITIS C AND B VIRUS INFECTIONS AS RISK FACTORS FOR SEVERE LIVER COMPLICATIONS FOLLOWING ALLOGENEIC BMT: A PROSPECTIVE STUDY BY THE INFECTIOUS DISEASE WORKING PARTY OF THE EUROPEAN BLOOD AND MARROW TRANSPLANTATION GROUP1. Transplantation. 68(10). 1486–1491. 62 indexed citations

10.

Albertí, A., Andrea Pettenazzo, G Enzi, et al.. (1998). Uptake and degradation of Curosurf after tracheal administration to newborn and adult rabbits. European Respiratory Journal. 12(2). 294–300. 9 indexed citations

11.

Albertí, A., P.L. Almasio, Antonio Ascione, et al.. (1997). Guidelines for the treatment of chronic viral hepatitis. 29(6). 597–600. 4 indexed citations

12.

Benvegnù, Luisa, Giovanna Fattovich, L. Chemello, Franco Noventa, & A. Albertí. (1996). Retrospective analysis of the effect of interferon therapy on hepatocellular carcinoma (HCC) development in cirrhosis. Hepatology. 24. 396–396. 1 indexed citations

13.

Bortolotti, Flavia, Stéfan Wirth, Carlo Crivellaro, et al.. (1996). Long‐Term Persistence of Hepatitis B Virus DNA in the Serum of Children with Chronic Hepatitis B after Hepatitis B e Antigen to Antibody Seroconversion. Journal of Pediatric Gastroenterology and Nutrition. 22(3). 270–274. 2 indexed citations

14.

Diodati, G., C. Casarin, Sergio Scaccabarozzi, et al.. (1994). Interferon antibodies in patients with chronic hepatitic C virus infection treated with recombinant interferon alpha-2α. Journal of Hepatology. 20(3). 416–420. 42 indexed citations

15.

Bortolotti, Flavia, Pietro Vajro, P Cadrobbi, et al.. (1992). Cryptogenic chronic liver disease and hepatitis C virus infection in children. Journal of Hepatology. 15(1-2). 73–76. 35 indexed citations

16.

Giustina, G., L. Brollo, S. Favarato, et al.. (1992). Chronic hepatitis B: a controlled trial of thymopentin therapy in HBV-DNA positive patients. Journal of Hepatology. 17. 38–38. 3 indexed citations

17.

Ruffatti, Amelia, et al.. (1992). Hepatitis C Virus Infection in Hemodialyzed Patients Detected by First and Second Generation Assays. The Nephron journals/Nephron journals. 61(3). 344–345. 4 indexed citations

18.

Lau, Johnson Y. N., Graeme Alexander, & A. Albertí. (1991). Viral hepatitis.. Gut. 32(Suppl). S47–S62. 12 indexed citations

19.

Fattovich, Giovanna, A. Albertí, F. Tremolada, et al.. (1984). Liver disease in chronic hepatitis B virus (HBV) infection: relation to HBeAg and anti-HBe status. 16. 146–146. 1 indexed citations

20.

Albertí, A., et al.. (1978). Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection.. BMJ. 2(6144). 1056–1058. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact